
ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, and Pfizer are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders in the form of cash payments (dividends) or additional shares. Typically issued by mature, financially stable firms, they offer investors a combination of steady income and the potential for long-term capital appreciation. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
ProShares UltraPro Short QQQ stock traded down $0.15 during mid-day trading on Tuesday, reaching $19.04. 70,650,063 shares of the company's stock traded hands, compared to its average volume of 65,507,019. ProShares UltraPro Short QQQ has a 12-month low of $18.73 and a 12-month high of $57.95. The stock has a 50 day moving average of $22.85 and a two-hundred day moving average of $29.60.
Read Our Latest Research Report on SQQQ
Direxion Daily TSLA Bull 2X Shares (TSLL)
Shares of Direxion Daily TSLA Bull 2X Shares stock traded down $0.43 during midday trading on Tuesday, hitting $11.10. The company had a trading volume of 97,082,720 shares, compared to its average volume of 117,769,841. The stock has a market cap of $6.39 billion, a price-to-earnings ratio of 88.55 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 12-month low of $6.29 and a 12-month high of $41.50. The company has a fifty day simple moving average of $12.76 and a 200 day simple moving average of $15.02.
Read Our Latest Research Report on TSLL
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Shares of PFE stock traded down $0.79 on Tuesday, hitting $24.57. 37,675,424 shares of the stock traded hands, compared to its average volume of 45,693,203. The firm's 50-day moving average price is $23.92 and its two-hundred day moving average price is $24.77. Pfizer has a twelve month low of $20.92 and a twelve month high of $31.54. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.96 and a current ratio of 1.26. The stock has a market capitalization of $139.66 billion, a PE ratio of 17.81, a PEG ratio of 0.93 and a beta of 0.58.
Read Our Latest Research Report on PFE
Read More
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.